Cargando…
Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects
BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerot...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627806/ https://www.ncbi.nlm.nih.gov/pubmed/36341208 http://dx.doi.org/10.1016/j.jacasi.2021.09.003 |
_version_ | 1784823052679249920 |
---|---|
author | Kataoka, Yu Harada-Shiba, Mariko Hori, Mika Watanabe, Makoto Kokubo, Yoshihiro Noguchi, Teruo Yasuda, Satoshi Miyamoto, Yoshihiro |
author_facet | Kataoka, Yu Harada-Shiba, Mariko Hori, Mika Watanabe, Makoto Kokubo, Yoshihiro Noguchi, Teruo Yasuda, Satoshi Miyamoto, Yoshihiro |
author_sort | Kataoka, Yu |
collection | PubMed |
description | BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerotic cardiovascular events. METHODS: We investigated 1,436 statin-naive Japanese subjects without any cardiovascular disease in the Suita Study, an epidemiologic Japanese cohort study. Total, mature, and furin-cleaved PCSK9 levels were measured by means of enzyme-linked immunosorbent assay. The occurrence of coronary and stroke events were compared in subjects stratified by PCSK9 level tertile. RESULTS: Total, mature, and furin-cleaved PCSK9 levels were associated with non–high-density lipoprotein cholesterol (all P < 0.001) and systolic blood pressure (P = 0.001, P = 0.004, and P < 0.001, respectively). Furthermore, only furin-cleaved PCSK9 level was correlated to high-sensitivity C-reactive protein (hs-CRP) (P < 0.001). During the 13.6-year observational period, furin-cleaved PCSK9 level predicted a greater likelihood of experiencing coronary events (tertile 2: hazard ratio [HR]: 2.84 [95% confidence interval [CI]: 1.21-6.65; P = 0.01]; tertile 3: HR: 2.81 [95% CI: 1.17-6.74; P = 0.02]), but not stroke (tertile 2: HR: 1.31 [95% CI: 0.72-2.40; P = 0.36]; tertile 3: HR: 1.27 [95% CI: 0.68-2.38; P = 0.44]). Total and mature PCSK9 levels were not associated with coronary events (total PCSK9: tertile 2: HR: 1.35 [95% CI: 0.68-2.68; P = 0.39]; tertile 3: HR: 1.13 [95% CI: 0.54-2.34; P = 0.73]; mature PCSK9: tertile 2: HR: 1.02 [95% CI: 0.52-2.02; P = 0.93]; tertile 3: HR: 0.96 [95% CI: 0.47-1.95; P = 0.92]) and stroke events (total PCSK9: tertile 2: HR: 0.90 [95% CI: 0.50-1.61; P = 0.72]; tertile 3: HR: 0.99 [95% CI:0.54-1.80; P = 0.97]; mature PCSK9: tertile 2: HR: 0.86 [95% CI: 0.47-1.57; P = 0.63]; tertile 3: HR: 1.11 [95% CI: 0.61-1.99; P = 0.72]), respectively. CONCLUSIONS: Furin-cleaved but not total and mature PCSK9 was associated with both LDL cholesterol and hs-CRP and predicted future coronary events in the primary prevention settings. Our findings provide pathophysiological insights into the properties of PCSK9 subtypes in association with coronary events. |
format | Online Article Text |
id | pubmed-9627806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96278062022-11-04 Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects Kataoka, Yu Harada-Shiba, Mariko Hori, Mika Watanabe, Makoto Kokubo, Yoshihiro Noguchi, Teruo Yasuda, Satoshi Miyamoto, Yoshihiro JACC Asia Original Research BACKGROUND: Proprotein convertase subtilisin/kexin type 9 (PCSK9) circulates as mature and furin-cleaved forms, which differ in their properties to degrade low-density lipoprotein (LDL) receptors. OBJECTIVES: In this study, we sought to investigate whether PCSK9 subtypes associate with atherosclerotic cardiovascular events. METHODS: We investigated 1,436 statin-naive Japanese subjects without any cardiovascular disease in the Suita Study, an epidemiologic Japanese cohort study. Total, mature, and furin-cleaved PCSK9 levels were measured by means of enzyme-linked immunosorbent assay. The occurrence of coronary and stroke events were compared in subjects stratified by PCSK9 level tertile. RESULTS: Total, mature, and furin-cleaved PCSK9 levels were associated with non–high-density lipoprotein cholesterol (all P < 0.001) and systolic blood pressure (P = 0.001, P = 0.004, and P < 0.001, respectively). Furthermore, only furin-cleaved PCSK9 level was correlated to high-sensitivity C-reactive protein (hs-CRP) (P < 0.001). During the 13.6-year observational period, furin-cleaved PCSK9 level predicted a greater likelihood of experiencing coronary events (tertile 2: hazard ratio [HR]: 2.84 [95% confidence interval [CI]: 1.21-6.65; P = 0.01]; tertile 3: HR: 2.81 [95% CI: 1.17-6.74; P = 0.02]), but not stroke (tertile 2: HR: 1.31 [95% CI: 0.72-2.40; P = 0.36]; tertile 3: HR: 1.27 [95% CI: 0.68-2.38; P = 0.44]). Total and mature PCSK9 levels were not associated with coronary events (total PCSK9: tertile 2: HR: 1.35 [95% CI: 0.68-2.68; P = 0.39]; tertile 3: HR: 1.13 [95% CI: 0.54-2.34; P = 0.73]; mature PCSK9: tertile 2: HR: 1.02 [95% CI: 0.52-2.02; P = 0.93]; tertile 3: HR: 0.96 [95% CI: 0.47-1.95; P = 0.92]) and stroke events (total PCSK9: tertile 2: HR: 0.90 [95% CI: 0.50-1.61; P = 0.72]; tertile 3: HR: 0.99 [95% CI:0.54-1.80; P = 0.97]; mature PCSK9: tertile 2: HR: 0.86 [95% CI: 0.47-1.57; P = 0.63]; tertile 3: HR: 1.11 [95% CI: 0.61-1.99; P = 0.72]), respectively. CONCLUSIONS: Furin-cleaved but not total and mature PCSK9 was associated with both LDL cholesterol and hs-CRP and predicted future coronary events in the primary prevention settings. Our findings provide pathophysiological insights into the properties of PCSK9 subtypes in association with coronary events. Elsevier 2021-11-23 /pmc/articles/PMC9627806/ /pubmed/36341208 http://dx.doi.org/10.1016/j.jacasi.2021.09.003 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Kataoka, Yu Harada-Shiba, Mariko Hori, Mika Watanabe, Makoto Kokubo, Yoshihiro Noguchi, Teruo Yasuda, Satoshi Miyamoto, Yoshihiro Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title | Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title_full | Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title_fullStr | Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title_full_unstemmed | Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title_short | Circulating Furin-Cleaved Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Predicts Future Coronary Events in Japanese Subjects |
title_sort | circulating furin-cleaved proprotein convertase subtilisin/kexin type 9 concentration predicts future coronary events in japanese subjects |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627806/ https://www.ncbi.nlm.nih.gov/pubmed/36341208 http://dx.doi.org/10.1016/j.jacasi.2021.09.003 |
work_keys_str_mv | AT kataokayu circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT haradashibamariko circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT horimika circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT watanabemakoto circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT kokuboyoshihiro circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT noguchiteruo circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT yasudasatoshi circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects AT miyamotoyoshihiro circulatingfurincleavedproproteinconvertasesubtilisinkexintype9concentrationpredictsfuturecoronaryeventsinjapanesesubjects |